NeuroVoices: Stewart Tepper, MD, on Understanding Newly Approved STS101 for Acute Migraine (Audio) — NeurologyLive

Listen to story - Features Stewart Tepper, MD, a clinical professor of neurology, in an interview about the approval of STS101, a nasal powder agent, as a new treatment for patients with acute migraine.